Pura Vida Investments’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-100,000
Closed -$8.5M 241
2020
Q3
$8.5M Sell
100,000
-45,445
-31% -$2.3M 0.44% 44
2020
Q2
$5.16M Buy
+145,445
New +$4.25M 0.5% 49
2018
Q3
Sell
-50,400
Closed -$1.19M 148
2018
Q2
$1.19M Buy
+50,400
New +$1.01M 0.48% 65
2017
Q3
Sell
-256,800
Closed -$2.27M 101
2017
Q2
$2.27M Sell
256,800
-288,200
-53% -$2.02M 0.9% 37
2017
Q1
$3.53M Buy
545,000
+208,500
+62% +$1.06M 1.04% 45
2016
Q4
$1.24M Buy
336,500
+16,935
+5% +$50.1K 0.45% 52
2016
Q3
$1.04M Buy
319,565
+202,822
+174% +$567K 0.32% 70
2016
Q2
$271K Buy
116,743
+44,243
+61% +$148K 0.12% 70
2016
Q1
$181K Buy
+72,500
New +$163K 0.08% 74

Pura Vida Investments's IMMU Position: Q4 2020 in Review

Pura Vida Investments sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 100,000 shares — an estimated $8.5M sold.

Pura Vida Investments first reported a position in IMMU in Q1 2016 and held it in 9 quarters. The position peaked at $8.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Pura Vida Investments reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Pura Vida Investments sold 100,000 Immunomedics Inc shares in Q4 2020, an estimated $8.5M.
  • Pura Vida Investments first reported a position in Immunomedics Inc in Q1 2016 and held it in 9 quarters.
  • Pura Vida Investments's Immunomedics Inc position peaked at $8.5M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.